Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
63,439,729
-
Share change
-
+3,032,549
-
Total reported value
-
$397,760,786
-
Put/Call ratio
-
59%
-
Price per share
-
$6.27
-
Number of holders
-
115
-
Value change
-
+$20,831,383
-
Number of buys
-
57
-
Number of sells
-
34
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2022
As of 31 Dec 2022,
CYMABAY THERAPEUTICS INC - COM (CBAY) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,439,729 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, TCG Crossover Management, LLC, COMMODORE CAPITAL LP, VANGUARD GROUP INC, Nantahala Capital Management, LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., Octagon Capital Advisors LP, Foresite Capital Management IV, LLC, and Lynx1 Capital Management LP.
This page lists
115
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.